Market News & Trends
Avantor Completes Acquisition of RFCL Limited
Avantor Performance Materials Holdings S.A. recently announced it has completed its acquisition of RFCL Limited from ICICI Venture Funds Management Company Limited. Avantor, previously known…
Cytheris Announces Study Results Indicating CYT107 Expands CD4 T-Cells
Cytheris SA, a clinical-stage biopharmaceutical company focused on research and development of new therapies for immune modulation, recently announced results of a multi-center Phase IIa…
Elan Announces First European Commission Approval of Injectable Treatment Using NanoCrystal Technology
Elan Drug Technologies (EDT), the leading drug delivery unit of Elan Corporation, plc, recently announced that the first injectable product using EDT's NanoCrystal technology has…
Omthera Raises $33.9 Million to Fund Phase III Development
Omthera Pharmaceuticals, Inc., a privately held emerging specialty pharmaceuticals company, recently announced it has raised $33.9 million in a Series B funding round, led by…
Ricerca Biosciences Announces Strategic Collaboration With Fulcrum
Ricerca Biosciences, an integrated preclinical CRO providing services to the biopharmaceutical industry, recently announced a strategic partnership with Fulcrum Pharma, an Aptiv Solutions company, a…
Ethypharm Sells its Subsidiary in India
The pharmaceutical company Ethypharm recently announced it has sold all of its operations in India to Athena Pharm. Ethypharm leaves India in order to refocus…
ICIG to Acquire Pharmaceutical Intermediates Business From Genzyme
International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates…
Infinity Initiates Phase II Portion of Pancreatic Cancer Trial
Infinity Pharmaceuticals, Inc. recently announced the initiation of the randomized Phase II portion of the trial of IPI-926 in combination with gemcitabine (also known as…
Quintiles Supports Samsung's Entry Into Biopharmaceutical Market
Samsung Electronics Co., Ltd., the world's largest electronics company, and its affiliated companies (Samsung) recently announced they have entered into a strategic partnership with Quintiles,…
Studies Show Triolex for Parkinson's Disease Crosses the BBB in Mice
Harbor BioSciences, Inc., which is investigating the use the company's proprietary compound Triolex as a treatment for Parkinson's disease (PD) with funding from The Michael…
3/1/2011
Elan & PPD Announce Global Business Relationship in Drug Development Elan, plc and PPD, Inc. recently announced they have formed a global business collaboration focused…
Elan & PPD Announce Global Business Relationship in Drug Development
Elan, plc and PPD, Inc. recently announced they have formed a global business collaboration focused on the advancement, progression, and execution of Elan's development portfolio.…
BASF & Medi-Solve Coatings to Develop Multifunctional Coating Solutions for Medical Devices
BASF Future Business GmbH and Medi-Solve Coatings LLC recently announced a collaboration in the field of antimicrobial coatings for catheters and other minimally invasive medical…
Capsugel Acquires Novel FlexTab Delivery Technology
Capsugel, the world's leading hard capsule manufacturer and an innovator in drug delivery systems, recently announced its acquisition of the FlexTabTM technology, a novel dosage form…
Pantec Biosolutions Reports First Successful IVF Pregnancy Using P.L.E.A.S.E.
Pantec Biosolutions AG recently announced that a woman has successfully conceived after being implanted with a fertilized oocyte (egg cell). The oocyte donor was treated…
Progenics & Salix Announce Worldwide License Agreement
Progenics Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd. recently announced they have entered into an exclusive worldwide (except Japan) agreement by which Salix has licensed rights…
2/15/2011
BASF & Medi-Solve Coatings to Develop Multifunctional Coating Solutions for Medical Devices BASF Future Business GmbH and Medi-Solve Coatings LLC recently announced a collaboration in…
Particle Sciences & HORIBA Instruments Form Strategic Relationship
Particle Sciences, Inc., a leading pharmaceutical CRO, recently announced the establishment of a strategic alliance with HORIBA Instruments of Irvine, CA, which is the US…
Zogenix Announces Completion of Enrollment for ZX002 Phase III Efficacy Study
Zogenix, Inc. recently announced the completion of enrollment in its pivotal Phase III efficacy study (Study 801) of ZX002. ZX002 is a novel, oral, single-entity,…
Elestrin Estradiol Gel to be Launched in US With LABLABO's Airless Metering Dispenser
Azur Pharma recently launched a new Hormonal Replacement Treatment (HRT) on the US market, Elestrin 0.06% Estradiol Gel. A close collaboration with this Irish lab…
